Engagements

ICC dispute over breach of supply

CRA was retained by claimant to provide expert reports and testimony in an ICC arbitration regarding damages pursuant to the failure of a supply agreement pertaining to a pharmaceutical product. CRA evaluated pricing, market trends, and profitability related to its damages opinion.

Related Capabilities

Damages & Quantum
International Arbitration
Life Sciences Arbitration
Life Sciences Commercial Disputes
Life Sciences Litigation

Gregory K. Bell
Group Vice President and Life Sciences Practice Leader

Boston
+1-617-425-3357 gbell@crai.com
Archan Ruparel
he/him/his

Principal

Washington, DC
+1-202-662-3861 aruparel@crai.com

Damages & Quantum
CRA Insights

Life Sciences Litigation Insights: April 2022

CRA’s Life Sciences Litigation team provides periodic summaries of notable developments in litigation. In this issue, we share notable cases from 2021 and...
Antitrust & Competition
Podcast

Podcast: Factual Witness and Expert Evidence

In this eighth episode of Linklater’s “UK Competition Litigation Podcast Series,” CRA’s Oliver Latham joins Haidee Barratt and Alex Hannington to discuss the...

Explore our thinking

ICC dispute over breach of supply

Meet Our Team

Related Insights

Life Sciences Litigation Insights: April 2022

Podcast: Factual Witness and Expert Evidence